We are live on ! Find out more
WGSWW

GeneDx Holdings Warrant

Delisted

WGSWW was delisted on the 21st of July, 2026.

15 hedge funds and large institutions have $355K invested in GeneDx Holdings Warrant in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more capital invested

Capital invested by funds: $220K → $355K (+$135K)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

15% more funds holding

Funds holding: 1315 (+2)

10.95% less ownership

Funds ownership: 10.95%0% (-11%)

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
2
Closed
Calls
$23K
Puts
Net Calls
+$23K
Net Calls Change
+$7K

WGSWW Hedge Fund Activity: Q3 2025 in Review

15 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q3 2025, worth a combined $355K — up 61% from $220K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new WGSWW positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was LMR Partners, adding an estimated $8.26K. The largest seller was UBS Group, cutting an estimated $4.07K.

  • 15 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q3 2025, up from 13 in Q2 2025.
  • Funds reported $355K of GeneDx Holdings Warrant stock for Q3 2025, up 61% quarter-over-quarter.
  • 2 funds opened new GeneDx Holdings Warrant positions in Q3 2025 and 0 closed out, a net change of +2 holders.
  • The largest GeneDx Holdings Warrant buyer in Q3 2025 was LMR Partners, an estimated $8.26K added.
  • The largest GeneDx Holdings Warrant seller in Q3 2025 was UBS Group, an estimated $4.07K sold.

Based on aggregated 13F filings for Q3 2025.